Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial

Background: Overweight and hyperglycemia might result in poor prognosis in patients with severe community-acquired pneumonia (SCAP). XueBiJing treatment could significantly improve the outcomes of patients with SCAP. We investigated the efficacy of XueBiJing injection in patients with SCAP stratifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yansha, Wang, Xiaocen, Chen, Cuicui, Wei, Tingting, Lang, Ke, Yang, Dong, Song, Yuanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204492/
https://www.ncbi.nlm.nih.gov/pubmed/35721170
http://dx.doi.org/10.3389/fphar.2022.755536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204492/
https://www.ncbi.nlm.nih.gov/pubmed/35721170
http://dx.doi.org/10.3389/fphar.2022.755536

Ejemplares similares